Home
HomeChat
Markets
AlertsCalendarScreenerCharts
Portfolio
WatchlistsPortfolioFiles
Account
Docs
Sign upJoinLog inLogin

Absci Corporation (ABSI) stock profile

Absci Corporation, a drug and target discovery company, provides biologic drug candidates and production cell lines using an integrated drug creation platform for partners in the United States. Its integrated drug creation platform enables the creation of biologics by unifying the drug discovery and cell line development processes into one. Absci Corporation was founded in 2011 and is headquartered in Vancouver, Washington.

Key facts

SymbolABSI
ExchangeNASDAQ
SectorHealthcare
IndustryBiotechnology
CEOSean McClain
Employees140
HeadquartersVancouver, WA, US
IPO2021-07-22
Websitewww.absci.com

Explore ABSI on Vantafin

  • Absci Corporation Overview
  • Absci Corporation Financials
  • Absci Corporation News
  • Absci Corporation Events
  • Absci Corporation SEC filings
  • Absci Corporation Insider transactions
  • Absci Corporation Transcripts

Frequently asked questions

What does Absci Corporation (ABSI) do?
Absci Corporation, a drug and target discovery company, provides biologic drug candidates and production cell lines using an integrated drug creation platform for partners in the United States. Its integrated drug creation platform enables the creation of biologics by unifying the drug discovery and cell line development processes into one. Absci Corporation was founded in 2011 and is headquartered in Vancouver, Washington.
Where is ABSI stock listed?
Absci Corporation trades under the ticker ABSI on NASDAQ.
How can I research ABSI's financials and filings?
Vantafin provides Absci Corporation's income statement, balance sheet and cash-flow data, SEC filings, earnings-call transcripts, and insider & institutional ownership on the ABSI profile.